Prognostic value of left atrial strain in acute and chronic heart failure: A meta-analysis

Maria Concetta Pastore1, Mariangela Vigna1, Andrea Saglietto2

  • 1Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.

ESC Heart Failure
|April 21, 2025
PubMed

Insights

Peak atrial longitudinal strain (PALS) effectively predicts outcomes in heart failure (HF). Lower PALS indicates a higher risk of mortality and hospitalization, aiding in patient risk stratification.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Prognostics

Background:

  • Heart failure (HF) presents a significant global health challenge with complex prognostic assessment.
  • Speckle tracking left atrial strain is recognized for its predictive capabilities in HF outcomes.

Purpose of the Study:

  • To systematically evaluate the prognostic significance of peak atrial longitudinal strain (PALS) in both acute and chronic heart failure.
  • To analyze PALS's prognostic value across different left ventricular (LV) functions, age groups, and genders.

Main Methods:

  • A systematic literature search adhering to PRISMA principles was conducted across medical databases.
  • Meta-analysis of eight studies (n=5767) involving patients with reduced, mildly reduced, and preserved ejection fraction (EF) and ≥6 months follow-up.
  • Primary endpoints included all-cause mortality and HF hospitalization, analyzed using random-effect meta-analysis.

Main Results:

  • A decrease in global PALS was independently associated with a 5% increase in the primary endpoint (HR=1.05; P<0.01).
  • Subgroup analyses revealed no significant differences in prognostic value between acute and chronic HF.
  • Meta-regression indicated a stronger prognostic value of PALS in patients with lower left ventricular ejection fraction (LVEF).

Conclusions:

  • Global PALS serves as a valuable prognostic tool in both acute and chronic heart failure.
  • PALS offers additional independent value for risk stratification, particularly in patients with reduced LVEF.
  • This metric can enhance clinical practice by improving the accuracy of HF patient risk assessment.
Abstract